Press Releases

Date Title and Summary
Toggle Summary CyberKnife(R) System Extracranial Treatments Grow 75 Percent in Fiscal Year 2007 Demonstrating Radiosurgery Market Shift
U.S. Patients Treated with CyberKnife System for Lung Cancer Doubled and Prostate Cancer Quadrupled SUNNYVALE, Calif., Aug. 8 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that use of its CyberKnife(R) Robotic
Toggle Summary Accuray Reports Record Revenue in Fiscal Fourth Quarter and Fiscal Year Ended 2007
Click here for PDF version of this release - Revenue Growth of 166 Percent Year Over Year - - Total Backlog Reaches Record Level of $619 Million - SUNNYVALE, Calif., Aug 16, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Accuray Incorporated (Nasdaq: ARAY), the global leader in radiosurgery
Toggle Summary Accuray Board Approves Stock Repurchase Plan
SUNNYVALE, Calif., Aug. 30 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), today announced that its Board of Directors has approved a plan that authorizes the Company to repurchase shares of its common stock. Under the plan, the Company will have the ability to acquire up to $25
Toggle Summary Accuray Receives FDA Clearance for New Dose Calculation Technique for Body Radiosurgery
Worldwide Availability of Monte Carlo Dose Calculation Software Announced at European Radiation Oncology Meeting in Barcelona BARCELONA, Spain, Sept. 10 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that its Monte Carlo
Toggle Summary Accuray Incorporated's CEO to Speak at UBS Global Life Sciences Conference
SUNNYVALE, Calif., Sept. 24 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that its president and CEO, Euan S. Thomson, Ph.D., is scheduled to present a corporate update at the UBS Global Life Sciences Conference at the
Toggle Summary CyberKnife(R) System Shows Momentum as Treatment Option for Prostate Cancer
Accuray Achieves Patient Treatment Milestone on Third Anniversary of National Prostate Cancer Awareness Month SUNNYVALE, Calif., Sept. 25 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that more than 1,000 men have been
Toggle Summary Accuray to Webcast Senior Management Presentations at Analyst Day Event
SUNNYVALE, Calif., Oct 02, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced that it will provide a live webcast for its first ever Analyst Day event, and media and investors are invited to
Toggle Summary Hospital Corporation of America Purchases Seventh CyberKnife(R) System
Most Recent Purchase for Installation in United Kingdom SUNNYVALE, Calif., Oct. 4 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that leading healthcare services company, Hospital Corporation of America (HCA), has
Toggle Summary Accuray Incorporated to Report First Quarter Fiscal Year 2008 Financial Results
SUNNYVALE, Calif., Oct. 12 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced that it will report results for its first quarter fiscal year 2008, ending September 29, 2007, on Wednesday, November 7, 2007 after the market
Toggle Summary Accuray Incorporated to Host Investor and Analyst Meeting at ASTRO 2007
Live Webcast on Monday, October 29 at 5:00 p.m. PDT (8:00 p.m. EDT) SUNNYVALE, Calif., Oct. 23 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that it will host an investor and analyst meeting in conjunction with the 49th

*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.